Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neuroblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00054405
What this trial is testing

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Who this might be right for
Recurrent Neuroblastoma
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Not applicableActive Not RecruitingNCT04087902
What this trial is testing

Long-Term Longitudinal QoL in Patients Undergoing EEA

Who this might be right for
Pituitary TumorMeningiomaRathke Cleft Cysts+5 more
Ohio State University 400
Testing effectiveness (Phase 2)Study completedNCT00002825
What this trial is testing

Docetaxel in Treating Children With Recurrent Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT03291080
What this trial is testing

Oral Liquid 13-cis-retinoic Acid (13-CRA)

Who this might be right for
Neuroblastoma
Nova Laboratories Limited 20
Not applicableLooking for participantsNCT01050296
What this trial is testing

Molecular Analysis Of Solid Tumors

Who this might be right for
Pediatric Solid Tumors
St. Jude Children's Research Hospital 1,000
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT03061656
What this trial is testing

Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma

Who this might be right for
High Risk Neuroblastoma
Samsung Medical Center 40
Not applicableStudy completedNCT00904241
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 10,000
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Not applicableLooking for participantsNCT03088020
What this trial is testing

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

Who this might be right for
Congenital Central Hypoventilation Syndrome
Ilya Khaytin 1,000
Early research (Phase 1)Study completedNCT00002730
What this trial is testing

Chemotherapy in Treating Children With Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Testing effectiveness (Phase 2)Study completedNCT00601003
What this trial is testing

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma

Who this might be right for
NeuroblastomaMedulloblastoma
Giselle Sholler 112
Not applicableUnknownNCT02919046
What this trial is testing

Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children

Who this might be right for
Relapsed or Refractory Neuroblastoma
Sinobioway Cell Therapy Co., Ltd. 22
Early research (Phase 1)Study completedNCT00006480
What this trial is testing

Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01445379
What this trial is testing

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

Who this might be right for
SarcomaWilm's TumorLymphoma+1 more
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00093821
What this trial is testing

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Who this might be right for
Childhood Chronic Myelogenous LeukemiaChildhood Desmoplastic Small Round Cell TumorDisseminated Neuroblastoma+11 more
National Cancer Institute (NCI) 70
Next Page